{"id":13979,"date":"2019-09-09T11:33:35","date_gmt":"2019-09-09T15:33:35","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13979"},"modified":"2019-09-09T11:33:35","modified_gmt":"2019-09-09T15:33:35","slug":"purdue-pharma-touts-data-that-downplay-its-role-in-the-opioid-epidemic-new-analysis-shows","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13979","title":{"rendered":"Purdue Pharma touts data that downplay its role in the opioid epidemic, new analysis shows"},"content":{"rendered":"<p>(By David Armstrong for ST<em>A<\/em>T and Jeff Ernsthausen for Propublica)<\/p>\n<p><em>This story is a collaboration between STAT and ProPublica.<\/em><\/p>\n<p>Purdue Pharma has tried to\u00a0refute accusations that it fueled the opioid crisis\u00a0by arguing it was a small player in the U.S. market for prescription pain relievers. But a new\u00a0ProPublica\u00a0analysis of government data shows that the company, the maker of OxyContin, had a far bigger impact than it portrays.\u00a0 Continue reading<a href=\"https:\/\/www.statnews.com\/2019\/09\/09\/purdue-pharma-data-downplay-its-role-in-opioid-epidemic\/\"> article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By David Armstrong for STAT and Jeff Ernsthausen for Propublica) This story is a collaboration between STAT and ProPublica. Purdue<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-13979","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13979"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13979\/revisions"}],"predecessor-version":[{"id":13980,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13979\/revisions\/13980"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}